WallStreetZenWallStreetZen

NASDAQ: SNSE
Sensei Biotherapeutics Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

SNSE earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$34.1M
Current Profit Margin
0%

SNSE Return on Equity

Current Company
-44%
Current Industry
-63.5%
Current Market
188%
SNSE's Return on Equity (-44%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when SNSE announces earnings.

SNSE Return on Assets

Current Company
-38.6%
Current Industry
2.9%
SNSE is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

SNSE Return on Capital Employed

Current Company
-49.41%
Current Industry
19.5%
SNSE has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

SNSE vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
SNSE$0.00-$31.25M-$34.10MN/AN/A
SLGL$1.55M-$26.90M-$27.24M+64.50%N/A
EYEN$3.79k-$24.11M-$27.26M-99.94%N/A
GDTC$0.00-$2.80M-$3.18MN/AN/A
UBX$0.00-$36.23M-$39.86M-100.00%N/A
View Top Biotech Stocks

SNSE earnings dates

Next earnings date
May 7, 2024

Sensei Biotherapeutics Earnings & Revenue FAQ

What were SNSE's earnings last quarter?

On Invalid Date, Sensei Biotherapeutics (NASDAQ: SNSE) reported Q4 2023 earnings per share (EPS) of -$0.30, up 25% year over year. Total Sensei Biotherapeutics earnings for the quarter were -$7.41 million. In the same quarter last year, Sensei Biotherapeutics's earnings per share (EPS) was -$0.40.

If you're new to stock investing, here's how to buy Sensei Biotherapeutics stock.

What was SNSE's earnings growth in the past year?

As of Q2 2024, Sensei Biotherapeutics's earnings has grown year over year. Sensei Biotherapeutics's earnings in the past year totalled -$34.10 million.

What is SNSE's earnings date?

Sensei Biotherapeutics's earnings date is Invalid Date. Add SNSE to your watchlist to be reminded of SNSE's next earnings announcement.

What was SNSE's revenue last quarter?

On Invalid Date, Sensei Biotherapeutics (NASDAQ: SNSE) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Sensei Biotherapeutics's revenue was $0.00.

What was SNSE's revenue growth in the past year?

As of Q2 2024, Sensei Biotherapeutics's revenue has grown null year over year. Sensei Biotherapeutics's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.